Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)

Hong Kong · Delayed Price · Currency is HKD

4.800

+0.035 (0.73%)

Sep 11, 2026, 4:08 PM HKT

HKG:2576 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	531.96	512.54	551.16	573.14	549.22	466.18
Revenue Growth	3.79%	-7.01%	-3.84%	4.36%	17.81%	53.88%
Gross Profit	235.1	217.54	224.94	179	185.4	164.33
Operating Income	-58.08	-57.23	-265.05	-401.4	-485.44	-462.59
Net Income	-65.15	-42.85	-214.61	-346.78	-412.91	-479.61
Earnings Per Share	-0.12	-0.08	-0.39	-0.64	-0.77	-0.89
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Mainland China	517.29	497.87	522.09	567.57	545.01	464.48
Korea	1.71	1.77	5.3	2.72	1.26	-
Singapore	3.56	3.46	20.03	0.9	0.63	0.31
Others	3.35	2.96	2.8	1.96	0.32	0.22
The United States	-	6.49	0.93	-	-	-
Total	531.96	512.54	551.16	573.14	549.22	466.18

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,082	1,192	1,199	1,068	1,408	1,400
Total Debt	85.39	61.13	34.76	15.09	45.86	77.44
Net Cash (Debt)	996.46	1,131	1,165	1,053	1,362	1,322
Net Cash Growth	-11.88%	-2.91%	10.61%	-22.69%	3.01%	-17.63%
Net Cash Per Share	1.77	2.01	2.14	1.96	2.53	2.46

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	-39.38	-201.62	-351.16	-329.22	-217.53
Capital Expenditures	-	-3.04	-5.68	-4.36	-24.4	-30.1
Free Cash Flow	-	-42.43	-207.3	-355.52	-353.62	-247.63
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	44.20%	42.44%	40.81%	31.23%	33.76%	35.25%
Operating Margin	-10.92%	-11.16%	-48.09%	-70.04%	-88.39%	-99.23%
Pretax Margin	-13.07%	-9.89%	-39.45%	-62.18%	-76.94%	-102.88%
Profit Margin	-12.25%	-8.36%	-38.94%	-60.50%	-75.18%	-102.88%
FCF Margin	-	-8.28%	-37.61%	-62.03%	-64.39%	-53.12%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	102.92	-	-	-	-
PS Ratio	4.37	3.91	4.11	-	-	-